Our analysis of 138 advanced NSCLC cases with available clinical data and enough tissue identified age, hepatoid cytology and cribriform structure as the independent predictors for ROS1 rearrangement, which may help to find candidates for genomic alterations, especially when available tissue samples are limited. Here, ROS1 is linked to non-small cell lung carcinoma.